BlackRock, Inc. 13D and 13G filings for Global Blood Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-03 4:41 pm Purchase |
2021-12-31 | 13G | Global Blood Therapeutics, Inc. GBT |
BlackRock Inc. BLK |
5,353,056 8.300% |
1,669,796 (+45.33%) |
Filing |
| 2021-01-29 09:56 am Sale |
2020-12-31 | 13G | Global Blood Therapeutics, Inc. GBT |
BlackRock Inc. BLK |
3,683,260 6.000% |
-1,171,913 (-24.14%) |
Filing |